In this podcast episode, Dr. Michael Alonso, VP of Immunology and Pharmacology at Bolt Biotherapeutics, discusses how the company is developing cancer therapies that engage the innate immune system to generate robust anti-tumor responses.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
